{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:02:13Z","timestamp":1788447733895,"version":"build-2803163510"},"reference-count":20,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202264010","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T19:23:33Z","timestamp":1644866613000},"source":"Crossref","is-referenced-by-count":19,"title":["Tenofovir-induced renal and bone toxicity: report of two cases and literature review"],"prefix":"10.1590","volume":"64","author":[{"given":"Carlos Eduardo Andrade","family":"Fioroti","sequence":"first","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-1899","authenticated-orcid":false,"given":"Jesiree Igl\u00e9sias Quadros","family":"Distenhreft","sequence":"additional","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Bastos","family":"Paulino","sequence":"additional","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Lacchine","sequence":"additional","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Rodrigues","family":"Ramos","sequence":"additional","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos","family":"Seguro","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weverton Machado","family":"Luchi","sequence":"additional","affiliation":[{"name":"Universidade Federal do Esp\u00edrito Santo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/hiv.12878","article-title":"2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0","volume":"21","author":"Ryom L","year":"2020","journal-title":"HIV Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2215\/CJN.10051012","article-title":"Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study","volume":"8","author":"Zaidan M","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.kint.2020.01.018","article-title":"The spectrum of kidney biopsy findings in HIV-infected patients in the modern era","volume":"97","author":"Kudose S","year":"2020","journal-title":"Kidney Int"},{"key":"ref4","article-title":"Tenofovir nephrotoxicity: 2011 update","volume":"2011","author":"Fernandez-Fernandez B","year":"2011","journal-title":"AIDS Res Treat"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103055","article-title":"Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system","volume":"9","author":"Canale D","year":"2014","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1681\/ASN.2012080857","article-title":"Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?","volume":"24","author":"Tourret J","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.2008.252","article-title":"Rosiglitazone reverses tenofovir-induced nephrotoxicity","volume":"74","author":"Lib\u00f3rio AB","year":"2008","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/524061","article-title":"Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy","volume":"197","author":"Goicoechea M","year":"2008","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2055-6640(20)30248-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?","volume":"4","author":"Hill A","year":"2018","journal-title":"J Virus Erad"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/psp4.12481","article-title":"Probenecid-boosted tenofovir: a physiologically-based pharmacokinetic model-informed strategy for on-demand HIV preexposure prophylaxis","volume":"9","author":"Liu SN","year":"2020","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1177\/2325958220919231","article-title":"A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide","volume":"19","author":"Wassner C","year":"2020","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijid.2020.01.035","article-title":"Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: a meta-analysis of randomized controlled trials","volume":"93","author":"Tao X","year":"2020","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0000000000002699","article-title":"Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials","volume":"34","author":"Pilkington V","year":"2020","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00535-020-01680-0","article-title":"Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review","volume":"55","author":"Fraga RS","year":"2020","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/QAD.0000000000000353","article-title":"Relative contribution of HIV infection, demographics and body mass index to bone mineral density","volume":"28","author":"Cotter AG","year":"2014","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-017-0162-y","article-title":"Bone mineral density in people living with HIV: a narrative review of the literature","volume":"14","author":"Kruger MJ","year":"2017","journal-title":"AIDS Res Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jbmr.3665","article-title":"Tenofovir causes bone loss via decreased bone formation and increased bone resorption, which can be counteracted by dipyridamole in mice","volume":"34","author":"Conesa-Buend\u00eda FM","year":"2019","journal-title":"J Bone Miner Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/AAC.01096-13","article-title":"Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?","volume":"57","author":"Havens PL","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","first-page":"59","article-title":"Renal and bone toxicity with the use of tenofovir: understanding at the end","volume":"18","author":"Casado JL","year":"2016","journal-title":"AIDS Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.11606\/issn.1679-9836.v97i3p372-373","article-title":"Bone impairment in HIV-infected patients and tenofovir-induced osteomalacia as a differential diagnosis","volume":"97","author":"Freitas TQ","year":"2018","journal-title":"Rev Med (Sao Paulo)"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v64\/1678-9946-rimtsp-64-S1678-9946202264010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T19:23:53Z","timestamp":1644866633000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652022000100500&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"alternative-id":["S0036-46652022000100500"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202264010","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e10"}}